These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 15294974)

  • 1. pH-triggered microparticles for peptide vaccination.
    Haining WN; Anderson DG; Little SR; von Bergwelt-Baildon MS; Cardoso AA; Alves P; Kosmatopoulos K; Nadler LM; Langer R; Kohane DS
    J Immunol; 2004 Aug; 173(4):2578-85. PubMed ID: 15294974
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Exosomes as potent cell-free peptide-based vaccine. I. Dendritic cell-derived exosomes transfer functional MHC class I/peptide complexes to dendritic cells.
    André F; Chaput N; Schartz NE; Flament C; Aubert N; Bernard J; Lemonnier F; Raposo G; Escudier B; Hsu DH; Tursz T; Amigorena S; Angevin E; Zitvogel L
    J Immunol; 2004 Feb; 172(4):2126-36. PubMed ID: 14764678
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Encapsulation of peptides in biodegradable microspheres prolongs their MHC class-I presentation by dendritic cells and macrophages in vitro.
    Audran R; Peter K; Dannull J; Men Y; Scandella E; Groettrup M; Gander B; Corradin G
    Vaccine; 2003 Mar; 21(11-12):1250-5. PubMed ID: 12559806
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Factors affecting the efficiency of CD8+ T cell cross-priming with exogenous antigens.
    Maecker HT; Ghanekar SA; Suni MA; He XS; Picker LJ; Maino VC
    J Immunol; 2001 Jun; 166(12):7268-75. PubMed ID: 11390476
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dendritic cells process synthetic long peptides better than whole protein, improving antigen presentation and T-cell activation.
    Rosalia RA; Quakkelaar ED; Redeker A; Khan S; Camps M; Drijfhout JW; Silva AL; Jiskoot W; van Hall T; van Veelen PA; Janssen G; Franken K; Cruz LJ; Tromp A; Oostendorp J; van der Burg SH; Ossendorp F; Melief CJ
    Eur J Immunol; 2013 Oct; 43(10):2554-65. PubMed ID: 23836147
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Liposomal delivery of CTL epitopes to dendritic cells.
    Chikh G; Schutze-Redelmeier MP
    Biosci Rep; 2002 Apr; 22(2):339-53. PubMed ID: 12428909
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lung CD103+ dendritic cells efficiently transport influenza virus to the lymph node and load viral antigen onto MHC class I for presentation to CD8 T cells.
    Ho AW; Prabhu N; Betts RJ; Ge MQ; Dai X; Hutchinson PE; Lew FC; Wong KL; Hanson BJ; Macary PA; Kemeny DM
    J Immunol; 2011 Dec; 187(11):6011-21. PubMed ID: 22043017
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vaccination with an acidic polymerase epitope of influenza virus elicits a potent antiviral T cell response but delayed clearance of an influenza virus challenge.
    Crowe SR; Miller SC; Shenyo RM; Woodland DL
    J Immunol; 2005 Jan; 174(2):696-701. PubMed ID: 15634888
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Follicular and marginal zone B cells fail to cross-present MHC class I-restricted epitopes derived from viral particles.
    Keller SA; von Allmen CE; Hinton HJ; Bauer M; Muntwiler S; Dietmeier K; Saudan P; Bachmann MF
    J Immunol; 2009 May; 182(10):6261-6. PubMed ID: 19414779
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cross-priming of T cell responses by synthetic microspheres carrying a CD8+ T cell epitope requires an adjuvant signal.
    Boisgérault F; Rueda P; Sun CM; Hervas-Stubbs S; Rojas M; Leclerc C
    J Immunol; 2005 Mar; 174(6):3432-9. PubMed ID: 15749877
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular and cellular requirements for enhanced antigen cross-presentation to CD8 cytotoxic T lymphocytes.
    Oizumi S; Strbo N; Pahwa S; Deyev V; Podack ER
    J Immunol; 2007 Aug; 179(4):2310-7. PubMed ID: 17675492
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficient delivery of Antennapedia homeodomain fused to CTL epitope with liposomes into dendritic cells results in the activation of CD8+ T cells.
    Chikh GG; Kong S; Bally MB; Meunier JC; Schutze-Redelmeier MP
    J Immunol; 2001 Dec; 167(11):6462-70. PubMed ID: 11714813
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Directed antigen presentation using polymeric microparticulate carriers degradable at lysosomal pH for controlled immune responses.
    Kwon YJ; Standley SM; Goodwin AP; Gillies ER; Fréchet JM
    Mol Pharm; 2005; 2(1):83-91. PubMed ID: 15804181
    [TBL] [Abstract][Full Text] [Related]  

  • 14. pH-triggered release of macromolecules from spray-dried polymethacrylate microparticles.
    Kohane DS; Anderson DG; Yu C; Langer R
    Pharm Res; 2003 Oct; 20(10):1533-8. PubMed ID: 14620503
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antigen co-encapsulated with adjuvants efficiently drive protective T cell immunity.
    Heit A; Schmitz F; Haas T; Busch DH; Wagner H
    Eur J Immunol; 2007 Aug; 37(8):2063-74. PubMed ID: 17628858
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bacterial heat shock proteins promote CD91-dependent class I MHC cross-presentation of chaperoned peptide to CD8+ T cells by cytosolic mechanisms in dendritic cells versus vacuolar mechanisms in macrophages.
    Tobian AA; Canaday DH; Boom WH; Harding CV
    J Immunol; 2004 May; 172(9):5277-86. PubMed ID: 15100266
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The importance of exogenous antigen in priming the human CD8+ T cell response: lessons from the EBV nuclear antigen EBNA1.
    Blake N; Haigh T; Shaka'a G; Croom-Carter D; Rickinson A
    J Immunol; 2000 Dec; 165(12):7078-87. PubMed ID: 11120837
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tumor-specific CD4+ T cells are activated by "cross-dressed" dendritic cells presenting peptide-MHC class II complexes acquired from cell-based cancer vaccines.
    Dolan BP; Gibbs KD; Ostrand-Rosenberg S
    J Immunol; 2006 Feb; 176(3):1447-55. PubMed ID: 16424172
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dendritic cells recruit T cell exosomes via exosomal LFA-1 leading to inhibition of CD8+ CTL responses through downregulation of peptide/MHC class I and Fas ligand-mediated cytotoxicity.
    Xie Y; Zhang H; Li W; Deng Y; Munegowda MA; Chibbar R; Qureshi M; Xiang J
    J Immunol; 2010 Nov; 185(9):5268-78. PubMed ID: 20881190
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Escherichia coli expressing recombinant antigen and listeriolysin O stimulate class I-restricted CD8+ T cells following uptake by human APC.
    Hu PQ; Tuma-Warrino RJ; Bryan MA; Mitchell KG; Higgins DE; Watkins SC; Salter RD
    J Immunol; 2004 Feb; 172(3):1595-601. PubMed ID: 14734740
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.